Medicare Enrolled

Dr. Gregory Ortega, MD

Hematology & Oncology · Orange City, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
2776 ENTERPRISE RD, Orange City, FL 32763
3867741223
In practice since 2006 (19 years)
NPI: 1720037989 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ortega from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ortega? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ortega

Dr. Gregory Ortega is a hematology & oncology in Orange City, FL, with 19 years in practice. Based on federal Medicare data, Dr. Ortega performed 64,005 Medicare services across 3,336 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ortega received a total of $13,190 from 14 pharmaceutical and/or device companies across 25 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ortega is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 13% volume in FL$ $13,190 industry payments

Medicare Practice Summary

Medicare Utilization ↗
64,005
Medicare services
Top 13% in FL for hematology & oncology
3,336
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,369 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Feraheme)24,990$0$2
Iron sucrose injection (Venofer)18,401$0$1
Denosumab injection (Prolia/Xgeva)5,340$19$43
Contrast dye for imaging (iodine-based)3,901$0$0
Complete blood count (CBC) with differential1,260$8$18
Dexamethasone injection (steroid)1,214$0$1
Blood draw (venipuncture)1,153$4$4
Office visit, established patient (20-29 min)867$65$219
Comprehensive metabolic blood panel855$10$29
Phosphate level test798$5$15
Anti-nausea injection (Aloxi/palonosetron)670$1$13
Ferritin level test (iron stores)363$13$39
Iron level test361$6$18
Iron binding capacity test360$9$24
Drug injection, under skin or into muscle303$10$76
Administration of chemotherapy into vein, 1 hour or less285$98$415
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less279$22$60
Lactate dehydrogenase (enzyme) level237$6$16
Administration of chemotherapy into vein, each additional hour163$21$90
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less158$47$117
Magnesium level test155$7$18
Vitamin B-12 level test132$15$43
Folic acid level test131$14$42
Injection of additional new drug or substance into vein130$12$41
Injection, diphenhydramine hcl, up to 50 mg127$1$2
Injection of drug or substance into vein125$27$92
Prothrombin time test (blood clotting)116$4$15
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional114$16$60
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg112$1$5
Carcinoembryonic antigen (cea) protein level98$19$49
Office visit, established patient (30-39 min)93$99$321
Thyroid stimulating hormone (TSH) test75$16$57
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-365$20$58
Nuclear medicine study from skull base to mid-thigh with ct scan64$1,103$3,475
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries61$402$560
Administration of additional new drug or substance into vein, 1 hour or less57$49$160
Hospital follow-up visit, moderate complexity56$63$213
PSA test (prostate cancer screening)50$18$52
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle50$53$123
Infusion into a vein for hydration, each additional hour40$10$30
Ct scan of chest with contrast35$86$979
CT scan of abdomen and pelvis with contrast31$163$987
Infusion into a vein for hydration, 31-60 minutes30$25$97
CT scan of chest, without contrast25$66$597
Irrigation of implanted venous access drug delivery device22$19$55
Initial hospital admission, high complexity22$138$605
New patient office visit (30-44 min)18$83$327
New patient office visit (45-59 min)13$116$500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
39.8% high complexity
48.4% medium
11.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$13,190
Total received (2018-2024)
Avg $2,198/year across 6 years
Top 33% in FL for hematology & oncology
14
Companies
25
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,992 (98.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$198 (1.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$39
2022
$42
2021
$102
2020
$11
2019
$11,204
2018
$1,791

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Tosoh Bioscience, Inc.
$12,340
TESARO, Inc.
$125
Takeda Pharmaceuticals U.S.A., Inc.
$124
Seagen Inc.
$102
Seattle Genetics, Inc.
$85
Janssen Biotech, Inc.
$85
E.R. Squibb & Sons, L.L.C.
$79
AstraZeneca Pharmaceuticals LP
$61
Bayer HealthCare Pharmaceuticals Inc.
$50
Exelixis Inc.
$48
Kite Pharma, Inc.
$33
Agios Pharmaceuticals, Inc.
$22
ABBVIE INC.
$19
Regeneron Healthcare Solutions, Inc.
$17
Top 3 companies account for 95.4% of total payments
Associated products mentioned in payments ›
AIA-PACK Calibrator Set · B12 · CALQUENCE · Cabometyx · Cystatin C · DARZALEX · IMFINZI · LIBTAYO · NINLARO · OPDIVO · PA · PADCEV · ST AIA-PACK · ST AIA-PACK Cystatin C Calibrator Set · TIBSOVO · TSH3G · VENCLEXTA · Xofigo · Yescarta · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $21 per 100 Medicare services performed
Looking for a hematology & oncology in Orange City?
Compare hematology & oncologys in the Orange City area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
22
Per 100K population
3.9
County median income
$66,581
Nearest hospital
ADVENTHEALTH FISH MEMORIAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ortega is a mixed practice specialist, with above-average Medicare volume (top 13% in FL), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ortega experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Ortega performed 24,990 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ortega receive payments from pharmaceutical companies?
Yes. Dr. Ortega received a total of $13,190 from 14 companies across 25 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ortega's costs compare to other hematology & oncologys in Orange City?
Dr. Ortega's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ortega) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →